compounded vs non compounded semaglutide FDA Warns of Overdoses from Versions of Ozempic, Wegovy Compound Semaglutide

Large numbers of biochemical problems over many years precede myocardial infarction (heart attack) and stroke

Rapid early losses are common on GLP-1 medications

About 1 in 8 adults are taking a GLP-1 drug for obesity, disease or both, up 6 percentage points from May 2024, according to KFF poll results released in November

So whats their secret superpower

When the body needs energy, hormones signal fat cells to release fatty acids into the bloodstream

doi: 10.3389/fmed.2026.1752341 Received 23 November 2025 Revised 04 April 2026 Accepted 10 April 2026 Published 29 April 2026 Volume 13 - 2026 Edited by Wei Liu, Huazhong University of Science and Technology, China Reviewed by Jheng-Yan Wu, Chi Mei Medical Center, Taiwan Jennifer Teske, University of Arizona, United States Updates Copyright 2026 Fang, Zhu, Rao and Liu